anorexia nervosa (anorexia)
Conditions
Interventions
All participants will receive 3 capsules of 764 mg EPA and 236 mg DHA daily for
a period of 8 weeks.
Sponsors
Academisch Medisch Centrum
Eligibility
Age
2 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * 10- to 19-years old (inclusive); * diagnosed with anorexia nervosa; * currently receiving inpatient or day treatment at De Bascule.
Exclusion criteria
Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * mental incapacity; * intellectual impairment as estimated or determined by a mental health professional (intelligence quotient of
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary parameters are inclusion rate, treatment adherence, and dropout rate. | — |
Secondary
| Measure | Time frame |
|---|---|
| A complete overview of the assessments is provided in Table 1 of the C1 research protocol. In addition to assessments that are completed as part of care as usual, we will monitor side effects at two time points. Furthermore, participants and one of their parents or legal guardians will be asked to complete two internationally validated assessment instruments at two time points (baseline and 8 weeks), namely: * the Dutch version of the Children*s Depression Inventory 2nd edition (CDI-2) (61), to assess depressive symptoms. The CDI-2 has adequate psychometric properties and has been validated in 8-21-year-old children and adolescents. * and the Dutch version of the Screen for Child Anxiety Related Emotional Disorders (SCARED-NL) (62), to assess anxiety symptoms. The SCARED-NL has adequate psychometric properties and has been validated in 7-19-year-old children and adolescents. | — |
Countries
Netherlands
Outcome results
None listed